Acadian Asset Management LLC Meira G Tx Holdings PLC Transaction History

Acadian Asset Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$5.78 - $7.33 $24,512 - $31,086	4,241 New	4,241 $25,000
Q2 2023 Aug 07, 2023	SELL	$5.19 - $8.07 $25,747 - $40,035	-4,961 Reduced 99.96%	2 $0
Q1 2023 May 11, 2023	SELL	$5.04 - $8.6 $307,712 - $525,064	-61,054 Reduced 92.48%	4,963 $25,000
Q4 2022 Feb 14, 2023	BUY	$5.8 - $8.98 $73,329 - $113,534	12,643 Added 23.69%	66,017 $426,000
Q3 2022 Nov 14, 2022	BUY	$7.55 - $11.25 $222,777 - $331,953	29,507 Added 123.63%	53,374 $445,000
Q2 2022 Aug 09, 2022	BUY	$6.8 - $14.23 $147,084 - $307,794	21,630 Added 966.92%	23,867 $180,000
Q1 2022 May 12, 2022	BUY	$13.42 - $23.38 $30,020 - $52,301	2,237 New	2,237 $30,000
Q2 2021 Aug 11, 2021	SELL	$12.85 - $16.2 $58,634 - $73,920	-4,563 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$11.59 - $14.93 $414,643 - $534,135	-35,776 Reduced 88.69%	4,563 $60,000
Q2 2020 Aug 12, 2020	SELL	$11.79 - $15.97 $47,949 - $64,949	-4,067 Reduced 9.16%	40,339 $506,000
Q1 2020 May 11, 2020	BUY	$9.31 - $21.24 $122,724 - $279,985	13,182 Added 42.22%	44,406 $597,000
Q4 2019 Feb 06, 2020	BUY	$13.91 - $21.48 $434,325 - $670,691	31,224 New	31,224 $625,000

39.7M

24.2K

30.7K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $192M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.